Background. Previous studies documented that humoral immune responses participated in neurological damage in neurosyphilis patients. However, the mechanisms that trigger and maintain humoral immunity involved in neurosyphilis remain unknown.
Treponema pallidum subsp. Pallidum (T. pallidum), the etiologic agent of syphilis, can disseminate into virtually any organ, including the central nervous system (CNS) [1] . Neuroinvasion with T. pallidum can lead to asymptomatic meningitis and cause severe, even irreversible, symptomatic neurosyphilis (NS) [2] . The mechanisms underlying the neurological damage of NS remain poorly understood.
As a result of T. pallidum infection, mammalian hosts mount robust cellular and humoral immune responses [3] . The response aims at spirochetal clearance, but it can also contribute to the pathogenesis. NS patients have a defective accumulation of CSF regulatory T cells, and their immunosuppressive cytokines may fail to suppress T-cell-mediated inflammation and tissue damage, resulting in neurological symptoms [4] . We previously reported that elevated T helper 17 (Th17)/interleukin (IL)-17 response confirms the role of cellular immunity in the inflammatory response and may be involved in CNS damage by NS [5] .
However, current studies are insufficient to explain the neurological damage caused by NS. Emerging evidence has demonstrated that humoral immunity contributes to pathological damage in the CNS of NS. Previous studies demonstrated higher levels of intrathecal immunoglobulin in CSF from NS patients, and it was positively correlated with disease severity [6] ; enrichment of B cells were observed in CSF from human immunodeficiency virus (HIV)-infected patients with NS [7] . The CNS affected by neuroimmunological disorders, such as neuroborreliosis (NB) [8] and multiple sclerosis (MS) [9, 10] , often contain numerous activated B cells, which are associated with the progression of the diseases. Identifying the mechanisms that lead to enrichment of B cells and abnormal B-cell response in CNS has significant potential for understanding neurological damage in NS.
B lymphocytes migrate in response to chemokine ligands CCL19, CCL21, CXCL12, and CXCL13 [11] . We have previously demonstrated that elevated CSF CXCL13 levels in NS patients [12] , which is primarily produced by follicular dendritic cells (FDCs), regulates homing and motility of both B cells and follicular helper CD4 T cells through its cognate receptor, CXCR5 [13] . In addition, elevated CXCL13 levels were also found in the CSF of patients with NB [14] , opsoclonus-myoclonus syndrome [15] , and other inflammatory neurological diseases [16] . However, how CXCL13/CXCR5 contributes to the recruitment of B lymphocytes into the CSF and how it regulates the B cells activation and antibody responses in CSF of NS patients are little known.
To explore the potential contribution of humoral immunity to NS pathogenesis, we studied B-cell infiltration in the CSF of NS patients and the relative intrathecal immunoglobulin levels. Upregulated expression of intrathecal CXCL13 serves as a key regulator for the recruitment of peripheral B cells into the CNS and the activation of aberrant antibody responses. The persistence and function of B cells/immunoglobulin-secreting cells might be relied on activated B cells fostering ectopic germinal centers (EGCs) in the CNS of NS patients. Our data provide a novel perspective to explain neurological damage by NS.
MATERIAL AND METHODS

Patient Samples
Participants were enrolled in Shanghai Skin Disease Hospital, from February 2015 to May 2016. Syphilis was diagnosed based on medical history, clinical manifestations, and the results of nontreponemal and treponemal tests of both serum samples and CSF. Peripheral blood was collected from healthy donors. Exclusion criteria for both patients and controls included HIV infection, prior syphilis or syphilis treatment, history of systemic inflammation, autoimmune disease, immunocompromised condition, or use of antibiotics or immunosuppressive medications in the last 4 weeks [4] . Written informed consent was obtained from all participants. This study was approved by the Ethics Committee of the Shanghai Skin Disease Hospital.
CSF (4-6 mL) from syphilis patients was used for CSF cell isolation immediately after a spinal tap. When less than 25 leukocytes per sample were counted and/or the erythrocyte cell count exceeded 3 cells/mL, these samples were excluded from the study. Brain tissue of left parietal cortex syphilitic gumma, a mass of granulation tissue resulting from the tertiary stage of syphilis, was obtained from 1 patient by surgical resection. CSF samples were grouped as follows:
1. NS group: 23 subjects with asymptomatic NS and 43 subjects with symptomatic NS (including 25 with general paresis, 12 with tabes dorsalis, and 6 with ocular NS). 2. Non-NS group: 4 subjects with primary syphilis, 27 subjects with secondary syphilis, 14 subjects with latent syphilis. 3. Control group: 15 subjects who underwent orthopedic or kidney stone surgery, whose CSF samples were used as controls.
Additional information on the patient groups is presented in Table 1 .
Diagnostic Criteria for Neurosyphilis
All neurosyphilis patients have positive serum rapid plasma regain and Treponema pallidum particle agglutination (TPPA) tests. The diagnosis of neurosyphilis were reactive CSF Venereal Disease Research Laboratory (VDRL) and CSF TPPA tests in the absence of substantial contamination of CSF with blood, or nonreactive CSF VDRL but reactive CSF TPPA with CSF protein concentration >45 mg/dL and/or CSF white blood cell (WBC) count ≥8/ μL. In this study, neurosyphilis is categorized as asymptomatic and symptomatic neurosyphilis. Asymptomatic neurosyphilis is defined by the presence of CSF abnormalities consistent with neurosyphilis and the absence of neurological and psychiatric signs or symptoms. Symptomatic neurosyphilis is characterized by the presence of CSF abnormalities consistent with neurosyphilis and psychiatric, neurological, and ocular manifestations.
Follow-Up
According to China's Guidelines for Diagnosis and Treatment of Syphilis, Gonorrhea, Genital Herpes, and Genital Chlamydia Trachomatis Infection [17] , NS patients were given aqueous crystalline penicillin G, 3-4 million units intravenously every 4 hours for 10-14 days, or 2 g ceftriaxone intravenously daily for 10-14 days if allergic to penicillin. All NS patients were asked for follow-up. Lumbar puncture was repeated at 3, 6, and 9 months if the CSF VDRL (-) and CSF-TPPA (+) (%)
Data are given as median (range), or frequencies.
Abbreviations: CSF, cerebrospinal fluid; HBV, hepatitis B virus; HIV, human immunodeficiency virus; NS, neurosyphilis; RPR, rapid plasma regain; TPPA, Treponema pallidum particle agglutination; VDRL, Venereal Disease Research Laboratory.
a "Duration of primary, secondary syphilis and symptomatic NS" means the duration of clinical manifestations; "Duration of latent syphilis" means the period between the patient's high-risk behaviors, which may be infected with T. pallidum, and the confirmation of both TPPA/RPR positive. "Duration of asymptomatic NS" means the period between the patient's high-risk behaviors, which may be infected with T. pallidum, and confirmed NS.
previous CSF profile was abnormal. CSF samples were collected at each follow-up visit. On the first and second follow-up, there were 36 and 17 patients to meet the requirement, respectively. 
Calculation of IgM, IgA, and IgG Indices
Albumin in CSF and serum samples was quantitatively determined by nephelometry. An immunoglobulin index was calculated to minimize the effect of alteration of blood-CSF barrier permeability on the absolute CSF immunoglobulin amount. IgM, IgA, and IgG indices were calculated using the following formulas:
Isolation and Stimulation of Human Peripheral B Cells
Peripheral blood mononuclear cells were isolated from healthy donors. Subsequent untouched B cells were isolated by Midi Macs System (Miltenyi Biotec, Bergisch Gladbach, Germany). B cells were incubated for 16 hours at 37°C and 5% CO 2 in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum, 20 ng/mL IL-4, and 1 μg/mL CD40L (PeproTech, Rocky Hill, NJ). After that, the cells were pelleted again and diluted to a working concentration of 2-3 × 10 6 cells/ mL for the chemotaxis and inhibition assays.
Chemotaxis Assay
The chemotaxis assay was performed in a disposable 24-well system (Corning) with polycarbonate membrane filters (5 μm pore). A total of 100 μL B-cell suspension was added to the upper compartment, and 600 μL of the CSF samples were added to the lower compartment. The chamber was incubated for 1 hour at 37°C in humidified air with 5% CO 2 . After incubation, cells migrating to the lower chamber were harvested, counted, and then surface stained for analysis by FACS. For better comparison of the results from different experimental groups, a chemotaxis index (CI) was calculated. We used medium as negative control value and 500 ng/mL recombinant human CXCL13 (R&D Systems) as a positive control.
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Inhibition Assay
To investigate the chemotactic impact of CXCL13 on the human B cells, the chemokines in the CSF samples from NS patients were blocked with neutralizing antibodies. For the blockade of CXCL13 activity, 10 μg/mL of the neutralizing polyclonal CXCL13 antibody or isotype control antibody (R&D Systems) was premixed with CSF samples by rocking at room temperature for 30 minutes before being transferred to transwell plates for chemotaxis assay. As a negative control, we used a mixture from 15 CSF samples from the control group, as they would represent the baseline of migratory activity in vivo, and 500 ng/ mL recombinant human CXCL13 served as a positive control.
To perform the assay, CSF samples from 21 NS patients were randomly selected.
Immunohistochemistry of Brain Tissues
Paraffin-embedded brain biopsy (4 μm) was stained with appropriate concentration of primary antibodies against CXCL13, CXCR5, CD20, CD3, CD35, CD138 (Maixin-Bio, Fujian, China), and spirochete (Biocare Medical, Pacheco, CA), then incubated with streptavidin-biotin complex system according to manufacturer's instructions (Boster, Pleasanton, CA).
Statistics
Data were expressed as median (interquartile range). The Mann-Whitney U test was used when 2 groups were compared. Differences between before and after treatment were analyzed by using a paired t test. Correlations between variables were assessed with Spearman's rank-order correlation coefficient.
The ρ values reported in the study were based on a 2-sided test with a significance level of P < .05.
RESULTS
Expanded CD19 + B-Cell and Memory B-Cell Subsets in CSF of NS Patients
The frequency of CD19 + B cells in NS patients was found to be significantly higher than that of non-NS patients, but the difference was not significant between asymptomatic and symptomatic NS (P < .001 and P = .266, respectively; Figure 1B ). We observed a significantly elevated percentage of memory B cells (P < .001; Figure 1B ), but a significant reduction of naive B cells in NS patients (P = .001; Figure 1B ) compared to non-NS patients. However, no significant differences were found in the percentage of plasmablasts and plasma cells between neurosyphilis and non-neurosyphilis patients (P = .485 and P = .192, respectively; Figure 1B ). There were no significant differences in proportion of CXCR5 + cells in B cells between neurosyphilis and non-neurosyphilis patients, neither between asymptomatic and symptomatic neurosyphilis patients (P = .086 and P = .378, respectively; Figure 1B ). For the longitudinal study, the percentage of CD19 + B cells consistently decreased after treatment (P = .007 and P < .001, respectively, for the first and second treatments; Figure 1C ). Finally, we noted that the frequency of CD19 + B cells in the CSF of NS patients was positively correlated with CSF WBC counts or CSF VDRL titer, but not CSF protein concentrations (P < .001, P = .003, and P = .588, respectively; Figure 1D ).
Magnified Antibody Responses in CSF of Patients With NS
We found that the index of IgM, IgA, and IgG was significantly higher in NS patients than that in non-NS patients (P < .001; Figure 2A ). Further work revealed that there was a higher index of IgM, IgA, and IgG in symptomatic NS compared with asymptomatic NS patients (P < .001; Figure 2A ). The IgM index significantly decreased after treatment and further decreased at the second follow-up; the IgA index displayed no decrease after treatment; the IgG index showed no decrease until the second follow-up ( Figure 2B ). All 3 immunoglobulin indices positively correlated with the frequency of B cells in CSF (P < .001, P = .016, and P = .001, respectively; Figure 2C ). We found no correlation between immunoglobulin indices and CSF WBC counts (P = .198, P = .142, and P = .323, respectively; Figure 2D ) or CSF protein concentrations (P = .105, P = .230, and P = .935, respectively; Figure 2D ). As shown in Figure 2D , a significantly positive correlation was found between immunoglobulin indices and CSF VDRL titer (P < .001, P = .002, and P = .014, respectively; Figure 2D ).
Significantly Elevated Expression of CXCL13 in CSF of Patients With NS
A significantly higher level of CSF CXCL13 was found in NS patients compared with non-NS patients and controls (P < .001; Figure 3A ). We further noted that the level of CSF CXCL13 in symptomatic NS patients was significantly higher than that in asymptomatic NS patients (P < .001; Figure 3A) . The CSF CXCL13 level was significantly decreased after the first treatment and further decreased at the second follow-up (P < .001 and P < .001, respectively; Figure 3A ). Correlation analysis found that the CSF CXCL13 level was positively correlated with the frequency of total B cells in CSF (P < .001; Figure 3B ), and with immunoglobulin indices (P < .001, P < .001, and P < .001, respectively; Figure 3C ). We also found that the CSF CXCL13 level was strongly correlated with CSF protein concentrations or CSF VDRL titer (P = .001 and P = .005, respectively; Figure 3D ).
CSF From Neurosyphilis Patients Directly Chemoattracted Memory B Cells in Vitro
The chemotaxis index (CI) of human B cells toward the CSF from NS patients was significantly higher than that from non-NS patients (P < .001; Figure 4B ). About 23% of the memory B cells and 31% of the plasmablasts migrated toward the CSF of NS patients, in contrast to 14% and 27% of those from non-NS patients (P < .001 and P < .001; Figure 4B ). A significantly less number of naive B cells migrated toward the CSF in NS patients compared to non-NS patients (P < .001; Figure 4B ). The CI of B cells toward the CSF of patients with NS was positively correlated with the CSF CXCL13 level (P = .004; Figure 4B ). The specific function of CXCL13 was again confirmed by the CXCL13 neutralizing experiment. The increase in migration of CXCR5 + B cells toward the CSF in NS patients was significantly abrogated (inhibition ratio 53%; Figure 4D ) after neutralizing CXCL13 in the CSF, resulting in significantly reduced CI (P < .001; Figure 4D ) as compared with the use of isotype antibody. Although other chemokines may also be responsible for B-cell migration into the CSF of NS patients, CXCL13 was certainly a major mediator of B-cell recruitment to the CSF of NS patients.
Identification of Follicle-like Structures and B-Cell Responses in the Intracranial Syphilitic Gumma
Histopathological examination was performed on the intracranial syphilitic gumma, which revealed that the central portion of the mass contained a necrotizing inflammatory material infiltrated with epithelioid cells and inflammatory cells ( Figure 5 , HE-1). The vessels showed severe endarteritis with endothelial cell swelling and hyperplasia ( Figure 5 , HE-2). Syphilitic gumma was disclosed with abundant lymphocytes and plasma cells, especially in the perivascular space ( Figure 5, HE-3) . Interestingly, we noted that there were several follicle-like structures in the intracranial syphilitic gumma ( Figure 5, HE-4) . Spirochete immunostaining highlighted many organisms, typical spiral and thread-like, in syphilitic gumma lesions ( Figure 5 , spirochete).
To further detect the cell composition in those structures, immunostaining was performed on serial cerebral sections of the intracranial syphilitic gumma. It revealed that EGCs contained CXCL13 + cells, numerous CXCR5 + cells and CD20 + B cells, CD3 + T cells, CD35 + FDCs, and CD138 + plasma cells. Immunohistochemical studies localized CXCL13 within the extracellular matrix and the perivascular infiltrates in intracranial syphilitic gumma ( Figure 5, CXCL13-1, 2) . CXCL13 + cells were scattered in the inflamed parenchyma ( Figure 5 , CXCL13-2, 3). CXCR5 staining showed strong expression in the inflammatory cells, and were mainly gathered around blood vessels ( Figure 5, CXCR5-1, 2, 3) . Images analysis showed an overlap between CXCL13 and CXCR5 positive locations because both were primarily infiltrated around blood vessels. B cells were found accumulating perivascularly in syphilitic gumma lesions ( Figure 5, CD20-1, 2, 3) . Within the leptomeninges, B cells formed large and compact aggregates ( Figure 5,  CD20-1, 4) . Perivascular cuffs in syphilitic gumma lesions contained CD3 + T cells ( Figure 5, CD3-1, 2, 3 ( Figure 5, CD3-3, 4) . CD35 + cells with a slender dendritic protrusion and oval nuclei typical of FDCs ( Figure 5 , CD35-1) were present within the lymphocyte aggregates, mainly including B cells and T cells ( Figure 5, CD35-2, 3 ). CD35 + FDCs formed a complex reticular network in intimate contact with the surrounding lymphocytes ( Figure 5, CD35-4) . Numerous CD138 + plasma cells were present around meningeal blood vessels ( Figure 5, CD138-1, 2, 3 ). Plasma cells were consistently found in association with intrameningeal B-cell clusters, in which they had a more peripheral distribution compared to B cells ( Figure 5, CD138-1, 4) .
DISCUSSION
Infection of syphilis leads to multistage disease progression, the ultimate form being neurosyphilis, which can cause severe damage to diverse tissues and organs [3] . We noted an expanded CD19 + B-cell population in the CSF of NS patients. Moreover, we also reported an increased number of memory B-cell subset but a decreased number of naive B-cell subset in the CSF of NS patients. Memory B cells in the CSF were activated, as suggested by the expression of costimulatory molecules on their surface and the capacity to produce proinflammatory cytokines such as interferon-γ were significant upregulated. Also, memory B cells expressed extremely high levels of CCR1, CCR2, and CCR4, and these receptors were likely to contribute to B-cell homing and retention inside the inflamed CNS [18] . CD27 + B cells could produce 5-to 100-fold more immunoglobulin than CD27 -cells, such as IgD + CD27 --naive B cells [19] . The results of correlation analysis showed a strong correlation among the CSF B cells, immunoglobulin indices, and CSF VDRL titer. Because CSF VDRL might be a reflection of the T. pallidum burden and the extent of CNS damage in patients with NS, the results indicated that CSF B cells and immunoglobulin indices were associated with the progress of the disease. Thus, we proposed that the CSF aberrant activation of B cells locally generated a large amount of immunoglobulins, which could prompt activation of aberrant humoral immunity.
CXCL13, which is also called B-cell-attracting chemokine 1, seemed to be the major determinant for B-cell recruitment to the CNS compartment in various neuroinflammatory diseases [15, 20] . Our data also indicated a significant upregulation of CXCL13 with intense staining around blood vessels, explaining the specific recruitment and trafficking of CXCR5 + lymphocytes from blood vessels partly to the CNS of NS patients. Recent retrospective studies suggested that CXCL13 was produced within active MS lesions [21] , and its CSF concentration was a prognostic marker for clinically isolated syndrome [22] . In this study, CXCL13 was also found to be highly elevated in CSF samples from untreated neurosyphilis patients and rapidly decreased during antibiotic therapies. Additionally, earlier research showed that elevated CSF CXCL13 levels rather reflected a strong humoral immune response in the CNS compartment than being specific for a particular disease entity [15] . In our study, the impacts of CXCL13 on the local humoral immune response were further enhanced by a strong correlation with immunoglobulin indices and CSF total B cells. Moreover, the level of CSF CXCL13 was positively associated with total CSF protein and CSF VDRL titer in NS patients. We suggest that the biology of CXCL13/CXCR5 played a potential role in neurological damage through chemotaxis of B cells to the regulation of chronic inflammation in the CNS. Interestingly, we noted the presence of several follicle-like structures in intracranial syphilitic gumma lesion. The idea that EGCs might exist in brain tissue of NS patients was supported by the following observations. First, this structure contained numerous CD20 + B cells and some CD3 + T cells, and the location of these cells was accordant to that of CXCR5 + cells. Second, we noted that CD35 + FDC cells and CXCL13 + cells displayed a co-localization and cytoplasmic processes intermingled with the surrounding lymphocytes. It was conceivable that FDCs produced CXCL13 which in turn would attract CXCR5-expressing B cells and T cells, allowing the formation of functional lymphocytic aggregates. Third, in experimental autoimmune encephalomyelitis, Th17 cells specifically induced EGCs in the CNS [23] , and we have previously reported increased Th17/IL-17 responses in neurosyphilis patients [5] . In this study, we provide the first evidence that EGCs containing B cells, T cells, plasma cells and FDCs expressing the lymphoid chemokine CXCL13 could form in close association with inflamed blood vessels in the CNS of NS patients. This finding was in line with earlier results on such structures in the brains of patients with MS, NB, and also animal models [23, 24] . These EGCs were likely to provide a microenvironment for B-cell maturation and might be involved in maintaining a compartmentalized sustained intrathecal B-cell antibody response [25] . It is suggestive that the formation of EGCs could represent an important step in disease exacerbation. We summarized the triggering and maintaining the mechanism of humoral immunity in the CSF of NS patients ( Figure  6 ). The development of EGCs may be initiated by circulating memory B cells extravasating in the meningeal connective tissue [26] and circulating memory B cells were recruited in the CNS by CXCL13, which was produced by FDCs from EGCs. Memory B cells, upon secondary antigen stimulation in EGCs, were differentiated into plasma cells that produce immunoglobulin. When the protective mechanisms of antiautoimmune reaction caused by abnormal B-cell activation were missing in CNS, EGCs allowed persistence of the chronic autoimmune reaction [27] . In conclusion, our findings demonstrated that CXCL13/CXCR5 mediated the recruitment and infiltration of B cells, especially memory B cells, in the CSF of NS patients. Once memory B cells were selectively recruited to the brain of neurosyphilis patients, stimulated secondary immune system responded efficiently and speedily for similar antigen in EGCs. Intrathecal immunoglobulins production might induce persistent neurological damage, and eventually, pathogenesis. All of these results might provide a novel insight to understand neurological damage by NS, especially symptomatic NS.
Notes
